Kurt, M. Et Al. 2005. Possible association between Budd-Chiari syndrome and gemtuzumab ozogamicin treatment in a patient with refractory acute myelogenous leukemia. AMERICAN JOURNAL OF HEMATOLOGY , vol.80, no.3 , 213-215.

Kurt, M., Shorbagi, A., Altundag, K., Elkiran, T., Gullu, I., & Kansu, E., (2005). Possible association between Budd-Chiari syndrome and gemtuzumab ozogamicin treatment in a patient with refractory acute myelogenous leukemia. AMERICAN JOURNAL OF HEMATOLOGY , vol.80, no.3, 213-215.

Kurt, MEVLÜT Et Al. "Possible association between Budd-Chiari syndrome and gemtuzumab ozogamicin treatment in a patient with refractory acute myelogenous leukemia," AMERICAN JOURNAL OF HEMATOLOGY , vol.80, no.3, 213-215, 2005

Kurt, MEVLÜT Et Al. "Possible association between Budd-Chiari syndrome and gemtuzumab ozogamicin treatment in a patient with refractory acute myelogenous leukemia." AMERICAN JOURNAL OF HEMATOLOGY , vol.80, no.3, pp.213-215, 2005

Kurt, M. Et Al. (2005) . "Possible association between Budd-Chiari syndrome and gemtuzumab ozogamicin treatment in a patient with refractory acute myelogenous leukemia." AMERICAN JOURNAL OF HEMATOLOGY , vol.80, no.3, pp.213-215.

@article{article, author={MEVLÜT KURT Et Al. }, title={Possible association between Budd-Chiari syndrome and gemtuzumab ozogamicin treatment in a patient with refractory acute myelogenous leukemia}, journal={AMERICAN JOURNAL OF HEMATOLOGY}, year=2005, pages={213-215} }